This compound is a chiral, bis-imidazole derivative featuring two pyrrolidine rings and a central biphenyl linker. It is primarily supplied as a pharmaceutical intermediate for research and manufacturing applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(S)-2-((1R,3aR,4S,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol
pharmaceutical intermediate
Levofloxacin q-acid
pharmaceutical intermediate
Benzenamine, N-phenyl-3-(trifluoromethyl)- (9CI)
pharmaceutical intermediate
N-benzyl-N-methylethanolamine
pharmaceutical intermediate
Bis(2-methyl-2-propanyl) (2S,2'S)-2,2'-[4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl)]di(1-pyrrolidinecarboxylate)
pharmaceutical intermediate
Daclatasvir
pharmaceutical raw material
Daclatasvir dihydrochloride
pharmaceutical raw material
The international HS code for 2-((2S)-Pyrrolidin-2-yl)-5-(4-(4-(2-((2S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)phenyl)-1himidazole tetrahydrochloride (CAS 1009119-83-8) is 2933.29.
2933.29
2933 29 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[(2S)-pyrrolidin-2-yl]-5-[4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazole;tetrahydrochloride
AYOXSBJGFNPGNK-VDUNKYASSA-N
C1C[C@H](NC1)C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6.Cl.Cl.Cl.Cl
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.